InPharm

Inpharm is a prominent pharmaceutical company based in Serbia that specializes in the distribution, representation, and marketing of medicines, medical devices, and dietary supplements. Founded in 2000, the company has established a significant presence in the Balkan region, including operations in Montenegro and Bosnia and Herzegovina. Inpharm provides comprehensive support to global pharmaceutical partners, offering services such as registration, pharmacovigilance, and clinical research organization (CRO) support. In 2023, the company was acquired by the Sun Wave Group, a leading Eastern European consumer healthcare company owned by the LetterOne investment fund. Inpharm's portfolio includes its own line of dietary supplements and a wide range of medical products, including vaccines and diagnostics.